A » Sourcing bulk generic pharmaceutical tablets directly from a UK manufacturer based in Nottingham requires a methodical approach that prioritises regulatory compliance, supply chain transparency, and quality assurance. Nottingham is historically home to a significant pharmaceutical presence, most notably through Boots, which maintains a strong heritage in pharmacy and has contract manufacturing capabilities; however, Boots no longer manufactures generic tablets in bulk for third‑party supply on a large scale. The most reliable route begins with consulting the Medicines and Healthcare products Regulatory Agency (MHRA) — specifically, the publicly accessible Register of Licensed Manufacturers and Wholesalers. This register lists all sites in the UK licensed to manufacture human medicines, including those in Nottingham, and indicates the manufacturing authorisation number, site address, and the scope of activities (e.g., solid oral dosage forms). Notable current manufacturers operating in or around Nottingham include Quotient Sciences (formerly Penn Pharmaceutical Services) in Ruddington, a contract development and manufacturing organisation (CDMO) that offers commercial‑scale production of generic tablets under strict Good Manufacturing Practice (GMP) standards. Another potential contact is Sterling Pharmaceutical Services (part of the Sterling Group) in the East Midlands region, though its main site is in Loughborough, close to Nottingham. To locate additional options, you can use the Association of British Pharmaceutical Industry (ABPI) directory for innovator firms and the British Generic Manufacturers Association (BGMA) for generic‑focused members; while neither is Nottingham‑specific, they can provide a list of UK‑based generic manufacturers who may have satellite facilities or partnerships in the area. For direct lead generation, consider subscribing to industry databases such as PharmaSources or CPHI Online, filtering by “UK,” “Nottingham,” and “tablets – generic.” Once you identify a potential supplier, you must verify that they hold a valid Manufacturer’s Licence from the MHRA and a Wholesale Distribution Authorisation if they also trade product. Request a copy of their latest MHRA inspection report and GMP certificate. It is also prudent to engage a qualified person (QP) to review the supplier’s quality system, as generics must demonstrate bioequivalence and stability. Commercial steps typically involve executing a confidentiality agreement, then issuing a request for quotation specifying the active pharmaceutical ingredient (API), dosage strength, packaging requirements, and delivery volumes. Many CDMOs in Nottingham are accustomed to handling export documentation, but you should confirm whether they require a minimum order quantity (MOQ) and whether they can supply in primary packaging (e.g., blister packs or bottles) or as loose bulk tablets. For additional assurance, attend industry exhibitions such as CPhI Worldwide, where UK manufacturers often exhibit, or contact the East Midlands Chamber of Commerce for introductions to local pharmaceutical companies. Finally, remember that the Medicines for Human Use (Clinical Trials) Regulations 2004 and Human Medicines Regulations 2012 govern all manufacturing activities, so ensure your sourcing complies with both UK law and the relevant import regulations of your destination country. By combining MHRA data with targeted outreach to CDMOs and trade bodies, you can identify reputable Nottingham‑based manufacturers capable of fulfilling a bulk generic tablets order.